Please wait while the formulary information is being retrieved.
METAPROTERENOL SULFATE (METAPROTERENOL SULFATE)
- Bronchospasm prevention
10 mg/5 mL oral syrup
- 10 milliliters (20 mg) by oral route 3 times per day
metaproterenol 10 mg/5 mL oral syrup
- 10 milliliters (20 mg) by oral route 3 times per day
metaproterenol 10 mg/5 mL oral syrup
- 10 milliliters (20 mg) by oral route 3 times per day
Bronchospasm prevention
- 10 milliliters (20 mg) by oral route 3 times per day
- 10 milliliters (20 mg) by oral route 4 times per day
- None
Contraindicated
- bromocriptine
- cabergoline
- Cafergot
- Compound 347
- Cycloset
- D.h.e.45
- dihydroergotamine
- enflurane
- ergoloid
- Ergomar
- ergotamine tartrate
- ergotamine-caffeine
- Forane
- isoflurane
- methylergonovine
- Migergot
- Migranal
- Parlodel
- sevoflurane
- Sojourn
- Terrell
- Ultane
Severe
Moderate
- None
- Tachyarrhythmia
Contraindicated
- Chronic heart failure
- Coronary artery disease
- Hypertension
- Myocardial ischemia
Severe
Moderate
- Diabetes mellitus
- Hyperthyroidism
- Seizure disorder
METAPROTERENOL SULFATE (METAPROTERENOL SULFATE)
- Bronchospasm prevention
- None
- Nausea
- Nervousness
More Frequent
Severe
Less Severe
- None
- Cramps
- Dizziness
- General weakness
- Headache disorder
- Hyperhidrosis
- Hypertension
- Tachycardia
- Tremor
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Chest pain
- Paradoxical bronchospasm
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Metaproterenol Sulfate
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Metaproterenol
Not contraindicated;Neonatal tachycardia,hypoglycemia,tremors possible
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Not contraindicated;Neonatal tachycardia,hypoglycemia,tremors possible |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Bronchospasm prevention | |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| J45.20 | Mild intermittent asthma, uncomplicated |
| J45.30 | Mild persistent asthma, uncomplicated |
| J45.40 | Moderate persistent asthma, uncomplicated |
| J45.50 | Severe persistent asthma, uncomplicated |
| J45.909 | Unspecified asthma, uncomplicated |
| J45.990 | Exercise induced bronchospasm |
| J45.998 | Other asthma |
| 0-9 | A-Z |
|---|---|
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| J45.20 | Mild intermittent asthma, uncomplicated |
| J45.30 | Mild persistent asthma, uncomplicated |
| J45.40 | Moderate persistent asthma, uncomplicated |
| J45.50 | Severe persistent asthma, uncomplicated |
| J45.909 | Unspecified asthma, uncomplicated |
| J45.990 | Exercise induced bronchospasm |
| J45.998 | Other asthma |
Formulary Reference Tool